Multiple species of G 1 cyclins and cyclin-dependent kinases are induced sequentially during G 1 phase, and the expression of cyclin A and cdc2 genes is subsequently induced at the G 1 /S boundary. To analyze the mechanism of cdc2 promoter activation, the 5-flanking region of the rat cdc2 gene was isolated and its structural features were characterized. The highly conserved sequence between human and rat cdc2 genes is present in the basal promoter region from positions ؊183 to ؊122, which contains the E box, Sp1, and E2F motifs. The expression of 5 sequential deletion derivatives of the promoter fused to luciferase cDNA in rat 3Y1 cells revealed the presence of the enhancer element. The presumed enhancer region was further analyzed by the introduction of base substitutions and by the formation of DNA-protein complexes with cell extracts prepared at various times during the G 1 -to-S-phase progression. These analyses revealed that the enhancer sequence, AAGTTACAAATA, located from ؊276 to ؊265, confers strong inducibility on the basal promoter at the G 1 /S boundary. The base substitutions introduced into the motifs of transcription factors indicated that the E2F motif is essential for the enhancer-dependent activation of the cdc2 promoter at the G 1 /S boundary. Electrophoretic mobility shift assays and DNase I footprinting showed that a factor which interacts with the enhancer element is induced late in G 1 phase.
Background: Expression of the rat cdc2 gene during G 1 -S phase progression is negatively and positively regulated by the silencer and enhancer elements located upstream of the basal promoter. The silencer and enhancer sequences resemble each other, but the silencer contains extra internal AG residues.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.